Skip to main content
Top
Published in: Diabetologia 4/2017

01-04-2017 | Article

Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes

Authors: Laura Marroqui, Reinaldo S. Dos Santos, Anne Op de beeck, Alexandra Coomans de Brachène, Lorella Marselli, Piero Marchetti, Decio L. Eizirik

Published in: Diabetologia | Issue 4/2017

Login to get access

Abstract

Aims/hypothesis

Three hallmarks of the pancreatic islets in early human type 1 diabetes are overexpression of HLA class I, endoplasmic reticulum (ER) stress and beta cell apoptosis. The mediators of these phenomena remain to be defined. The type I interferon IFNα is expressed in human islets from type 1 diabetes patients and mediates HLA class I overexpression. We presently evaluated the mechanisms involved in IFNα-induced HLA class I expression in human beta cells and determined whether this cytokine contributes to ER stress and apoptosis.

Methods

IFNα-induced inflammation, ER stress and apoptosis were evaluated by RT-PCR, western blot, immunofluorescence and nuclear dyes, and proteins involved in type I interferon signalling were inhibited by small interfering RNAs. All experiments were performed in human islets or human EndoC-βH1 cells.

Results

IFNα upregulates HLA class I, inflammation and ER stress markers in human beta cells via activation of the candidate gene TYK2, and the transcription factors signal transducer and activator of transcription 2 and IFN regulatory factor 9. Furthermore, it acts synergistically with IL-1β to induce beta cell apoptosis.

Conclusions/interpretation

The innate immune effects induced by IFNα may induce and amplify the adaptive immune response against human beta cells, indicating that IFNα has a central role in the early phases of diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Richardson SJ, Rodriguez-Calvo T, Gerling IC et al (2016) Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia 59:2448–2458CrossRefPubMedPubMedCentral Richardson SJ, Rodriguez-Calvo T, Gerling IC et al (2016) Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia 59:2448–2458CrossRefPubMedPubMedCentral
2.
go back to reference Richardson SJ, Morgan NG, Foulis AK (2014) Pancreatic pathology in type 1 diabetes mellitus. Endocr Pathol 25:80–92CrossRefPubMed Richardson SJ, Morgan NG, Foulis AK (2014) Pancreatic pathology in type 1 diabetes mellitus. Endocr Pathol 25:80–92CrossRefPubMed
3.
go back to reference Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55:2417–2420CrossRefPubMed Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55:2417–2420CrossRefPubMed
4.
go back to reference Tersey SA, Nishiki Y, Templin AT et al (2012) Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61:818–827CrossRefPubMedPubMedCentral Tersey SA, Nishiki Y, Templin AT et al (2012) Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61:818–827CrossRefPubMedPubMedCentral
5.
go back to reference Engin F, Yermalovich A, Nguyen T et al (2013) Restoration of the unfolded protein response in pancreatic β cells protects mice against type 1 diabetes. Sci Transl Med 5:211ra156CrossRefPubMedPubMedCentral Engin F, Yermalovich A, Nguyen T et al (2013) Restoration of the unfolded protein response in pancreatic β cells protects mice against type 1 diabetes. Sci Transl Med 5:211ra156CrossRefPubMedPubMedCentral
6.
go back to reference Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219–226CrossRefPubMed Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219–226CrossRefPubMed
7.
go back to reference Huang X, Yuang J, Goddard A et al (1995) Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658–664CrossRefPubMed Huang X, Yuang J, Goddard A et al (1995) Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658–664CrossRefPubMed
8.
go back to reference Somoza N, Vargas F, Roura-Mir C et al (1994) Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153:1360–1377PubMed Somoza N, Vargas F, Roura-Mir C et al (1994) Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153:1360–1377PubMed
9.
go back to reference Foulis AK, Farquharson MA, Meager A (1987) Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus. Lancet 2:1423–1427CrossRefPubMed Foulis AK, Farquharson MA, Meager A (1987) Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus. Lancet 2:1423–1427CrossRefPubMed
10.
go back to reference Dotta F, Censini S, van Halteren AG et al (2007) Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104:5115–5120CrossRefPubMedPubMedCentral Dotta F, Censini S, van Halteren AG et al (2007) Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104:5115–5120CrossRefPubMedPubMedCentral
11.
go back to reference Kay TW, Campbell IL, Oxbrow L, Harrison LC (1991) Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia 34:779–785CrossRefPubMed Kay TW, Campbell IL, Oxbrow L, Harrison LC (1991) Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia 34:779–785CrossRefPubMed
12.
go back to reference Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, McDevitt HO (2008) Interferon-α initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 105:12439–12444CrossRefPubMedPubMedCentral Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, McDevitt HO (2008) Interferon-α initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 105:12439–12444CrossRefPubMedPubMedCentral
13.
go back to reference Li Q, McDevitt HO (2011) The role of interferon alpha in initiation of type I diabetes in the NOD mouse. Clin Immunol 140:3–7CrossRefPubMed Li Q, McDevitt HO (2011) The role of interferon alpha in initiation of type I diabetes in the NOD mouse. Clin Immunol 140:3–7CrossRefPubMed
14.
go back to reference Kallionpaa H, Elo LL, Laajala E et al (2014) Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 63:2402–2414CrossRefPubMed Kallionpaa H, Elo LL, Laajala E et al (2014) Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 63:2402–2414CrossRefPubMed
15.
go back to reference Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63:2538–2550CrossRefPubMedPubMedCentral Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63:2538–2550CrossRefPubMedPubMedCentral
16.
go back to reference Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65:128–139PubMedPubMedCentral Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65:128–139PubMedPubMedCentral
17.
go back to reference Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33:9–21CrossRefPubMed Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33:9–21CrossRefPubMed
18.
go back to reference Lundberg M, Krogvold L, Kuric E, Dahl-Jorgensen K, Skog O (2016) Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes. Diabetes 65:3104–3110CrossRefPubMed Lundberg M, Krogvold L, Kuric E, Dahl-Jorgensen K, Skog O (2016) Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes. Diabetes 65:3104–3110CrossRefPubMed
19.
go back to reference Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260:1942–1946CrossRefPubMed Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260:1942–1946CrossRefPubMed
20.
21.
go back to reference Rhodes CJ, Taylor KW (1984) Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets. Diabetologia 27:601–603CrossRefPubMed Rhodes CJ, Taylor KW (1984) Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets. Diabetologia 27:601–603CrossRefPubMed
22.
go back to reference Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodstrom-Tullberg M (2013) Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol 87:7646–7654CrossRefPubMedPubMedCentral Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodstrom-Tullberg M (2013) Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol 87:7646–7654CrossRefPubMedPubMedCentral
23.
go back to reference Marroqui L, Dos Santos RS, Floyel T et al (2015) TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic beta cells. Diabetes 64:3808–3817CrossRefPubMed Marroqui L, Dos Santos RS, Floyel T et al (2015) TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic beta cells. Diabetes 64:3808–3817CrossRefPubMed
24.
go back to reference Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121:3589–3597CrossRefPubMedPubMedCentral Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121:3589–3597CrossRefPubMedPubMedCentral
25.
go back to reference Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β cell injury. Proc Natl Acad Sci U S A 91:9253–9256CrossRefPubMedPubMedCentral Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β cell injury. Proc Natl Acad Sci U S A 91:9253–9256CrossRefPubMedPubMedCentral
26.
go back to reference Brozzi F, Nardelli TR, Lopes M et al (2015) Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia 58:2307–2316CrossRefPubMed Brozzi F, Nardelli TR, Lopes M et al (2015) Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia 58:2307–2316CrossRefPubMed
27.
go back to reference Benner C, van der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedPubMedCentral Benner C, van der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedPubMedCentral
29.
go back to reference Santin I, Dos Santos RS, Eizirik DL (2016) Pancreatic beta cell survival and signaling pathways: effects of type 1 diabetes-associated genetic variants. Methods Mol Biol 1433:21–54CrossRefPubMed Santin I, Dos Santos RS, Eizirik DL (2016) Pancreatic beta cell survival and signaling pathways: effects of type 1 diabetes-associated genetic variants. Methods Mol Biol 1433:21–54CrossRefPubMed
30.
go back to reference Marroqui L, Santin I, Dos Santos RS, Marselli L, Marchetti P, Eizirik DL (2014) BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic β-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes 63:2516–2527CrossRefPubMed Marroqui L, Santin I, Dos Santos RS, Marselli L, Marchetti P, Eizirik DL (2014) BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic β-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes 63:2516–2527CrossRefPubMed
31.
go back to reference Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312CrossRefPubMed Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312CrossRefPubMed
32.
go back to reference Gonzalez-Navajas JM, Lee J, David M, Raz E (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125–135PubMedPubMedCentral Gonzalez-Navajas JM, Lee J, David M, Raz E (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125–135PubMedPubMedCentral
33.
go back to reference Abdul-Sater AA, Majoros A, Plumlee CR et al (2015) Different STAT transcription complexes drive early and delayed responses to type I IFNs. J Immunol 195:210–216CrossRefPubMedPubMedCentral Abdul-Sater AA, Majoros A, Plumlee CR et al (2015) Different STAT transcription complexes drive early and delayed responses to type I IFNs. J Immunol 195:210–216CrossRefPubMedPubMedCentral
34.
go back to reference Santin I, Moore F, Grieco FA, Marchetti P, Brancolini C, Eizirik DL (2012) USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis 3, e419CrossRefPubMedPubMedCentral Santin I, Moore F, Grieco FA, Marchetti P, Brancolini C, Eizirik DL (2012) USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis 3, e419CrossRefPubMedPubMedCentral
35.
go back to reference Miani M, Colli ML, Ladriere L, Cnop M, Eizirik DL (2012) Mild endoplasmic reticulum stress augments the proinflammatory effect of IL-1β in pancreatic rat β-cells via the IRE1α/XBP1s pathway. Endocrinology 153:3017–3028CrossRefPubMed Miani M, Colli ML, Ladriere L, Cnop M, Eizirik DL (2012) Mild endoplasmic reticulum stress augments the proinflammatory effect of IL-1β in pancreatic rat β-cells via the IRE1α/XBP1s pathway. Endocrinology 153:3017–3028CrossRefPubMed
36.
go back to reference Op de beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the β cells? Nat Rev Endocrinol 12:263–273CrossRefPubMed Op de beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the β cells? Nat Rev Endocrinol 12:263–273CrossRefPubMed
37.
go back to reference Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56:234–241CrossRefPubMed Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56:234–241CrossRefPubMed
38.
go back to reference Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42–61CrossRefPubMed Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42–61CrossRefPubMed
39.
go back to reference Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA (2008) Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1. Eur J Immunol 38:1194–1203CrossRefPubMedPubMedCentral Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA (2008) Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1. Eur J Immunol 38:1194–1203CrossRefPubMedPubMedCentral
40.
go back to reference Hu F, Yu X, Wang H et al (2011) ER stress and its regulator X-box-binding protein-1 enhance polyIC-induced innate immune response in dendritic cells. Eur J Immunol 41:1086–1097CrossRefPubMedPubMedCentral Hu F, Yu X, Wang H et al (2011) ER stress and its regulator X-box-binding protein-1 enhance polyIC-induced innate immune response in dendritic cells. Eur J Immunol 41:1086–1097CrossRefPubMedPubMedCentral
41.
go back to reference Cheng J, Liao Y, Zhou L, Peng S, Chen H, Yuan Z (2016) Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop. Sci Rep 6:20158CrossRefPubMedPubMedCentral Cheng J, Liao Y, Zhou L, Peng S, Chen H, Yuan Z (2016) Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop. Sci Rep 6:20158CrossRefPubMedPubMedCentral
42.
go back to reference Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56:185–193CrossRefPubMed Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56:185–193CrossRefPubMed
43.
go back to reference Krogvold L, Edwin B, Buanes T et al (2015) Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64:1682–1687CrossRefPubMed Krogvold L, Edwin B, Buanes T et al (2015) Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64:1682–1687CrossRefPubMed
44.
go back to reference Phelps EA, Cianciaruso C, Michael IP et al (2016) Aberrant accumulation of the diabetes autoantigen GAD65 in Golgi membranes in conditions of ER stress and autoimmunity. Diabetes 65:2686–2699CrossRefPubMed Phelps EA, Cianciaruso C, Michael IP et al (2016) Aberrant accumulation of the diabetes autoantigen GAD65 in Golgi membranes in conditions of ER stress and autoimmunity. Diabetes 65:2686–2699CrossRefPubMed
Metadata
Title
Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes
Authors
Laura Marroqui
Reinaldo S. Dos Santos
Anne Op de beeck
Alexandra Coomans de Brachène
Lorella Marselli
Piero Marchetti
Decio L. Eizirik
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 4/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4201-3

Other articles of this Issue 4/2017

Diabetologia 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.